Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Galatea Kallergi, Maria A. Papadaki, Eleni Politaki, +2

Breast Cancer Research

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Panayiotis A. Theodoropoulos, Hara Polioudaki, Sofia Agelaki, +4

Cancer Letters

Breast OncologyMedicineStem Cell MobilizationBiological MicroenvironmentsBlood Cell +9

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, +8

Clinical Cancer Research

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Galatea Kallergi, Sofia Agelaki, A. Kalykaki, +3

Breast Cancer Research

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Vasilis Georgoulias, V. Bozionelou, Sofia Agelaki, +6

Annals of Oncology

Tumor BiologyBreast OncologyEarly Breast CancerClinical RelapsesMedicine +7

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients

Galatea Kallergi, Harris Markomanolaki, Vicky Giannoukaraki, +6

Breast Cancer Research

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

Maria A. Papadaki, Galatea Kallergi, Zafeiris Zafeiriou, +5

BMC Cancer

Activation of FAK/PI3K/Rac1 Signaling Controls Actin Reorganization and Inhibits Cell Motility in Human Cancer Cells

Galatea Kallergi, Sofia Agelaki, Harris Markomanolaki, +2

Cellular Physiology and Biochemistry

Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients

Galatea Kallergi, Georgios Konstantinidis, Harris Markomanolaki, +5

Molecular Cancer Therapeutics

Breast OncologyOncologyCancer DetectionMedicineCtc Elimination +10

Phosphorylation of FAK, PI-3K, and Impaired Actin Organization in CK-positive Micrometastatic Breast Cancer Cells

Galatea Kallergi, Dimitris Mavroudis, Vassilis Georgoulias, +1

Molecular Medicine

Breast OncologyImpaired Actin OrganizationPathologyCytoskeletonCancer Biology +17